Caris Life Sciences, Inc. (CAI)
NASDAQ: CAI · Real-Time Price · USD
29.69
-0.01 (-0.03%)
Oct 12, 2026, 4:00 PM EDT - Market closed
Caris Life Sciences Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Bank of America Securities | Bank of America Securities | Buy Maintains $23 → $35 | Buy | Maintains | $23 → $35 | +17.88% | Oct 9, 2026 |
| Goldman Sachs | Goldman Sachs | Buy Maintains $27 → $35 | Buy | Maintains | $27 → $35 | +17.88% | Sep 21, 2026 |
Unknown Analyst UBS No rating | UBS | Hold Initiates $28 | Hold | Initiates | $28 | -5.69% | Sep 9, 2026 |
| BTIG | BTIG | Buy Reiterates $32 → $33 | Buy | Reiterates | $32 → $33 | +11.15% | Aug 7, 2026 |
| J.P. Morgan | J.P. Morgan | Buy Maintains $25 | Buy | Maintains | $25 | -15.80% | Aug 6, 2026 |
| Evercore ISI | Evercore ISI | Buy Maintains $25 → $26 | Buy | Maintains | $25 → $26 | -12.43% | Aug 6, 2026 |
| Piper Sandler | Piper Sandler | Hold Maintains $21 | Hold | Maintains | $21 | -29.27% | Aug 6, 2026 |
| Canaccord Genuity | Canaccord Genuity | Hold Reiterates $22 | Hold | Reiterates | $22 | -25.90% | Aug 6, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.